| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.
|
Hepatology
|
2004
|
6.98
|
|
2
|
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
|
Nat Med
|
2006
|
6.31
|
|
3
|
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.
|
J Heart Lung Transplant
|
2005
|
5.87
|
|
4
|
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
|
Am J Transplant
|
2003
|
4.54
|
|
5
|
Tolerogenic immunosuppression for organ transplantation.
|
Lancet
|
2003
|
4.09
|
|
6
|
Production of alpha 1,3-galactosyltransferase-deficient pigs.
|
Science
|
2002
|
3.96
|
|
7
|
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
|
Gastroenterology
|
2007
|
3.18
|
|
8
|
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas.
|
Hepatology
|
2006
|
2.08
|
|
9
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Liver Transpl
|
2002
|
2.07
|
|
10
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
|
J Am Coll Surg
|
2005
|
1.93
|
|
11
|
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys.
|
Clin Transplant
|
1989
|
1.74
|
|
12
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
Liver Transpl
|
2005
|
1.61
|
|
13
|
A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells.
|
Blood
|
2011
|
1.60
|
|
14
|
Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution.
|
Blood
|
2011
|
1.55
|
|
15
|
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
|
Hepatology
|
2002
|
1.54
|
|
16
|
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
|
Ann Surg
|
2003
|
1.52
|
|
17
|
Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells.
|
Eur J Immunol
|
2011
|
1.49
|
|
18
|
Acute antibody-mediated rejection of cardiac transplants.
|
J Heart Lung Transplant
|
2006
|
1.48
|
|
19
|
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
|
Transplantation
|
2004
|
1.43
|
|
20
|
MELD and prediction of post-liver transplantation survival.
|
Liver Transpl
|
2006
|
1.33
|
|
21
|
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
|
JAMA
|
2012
|
1.33
|
|
22
|
Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development.
|
Lab Invest
|
2008
|
1.32
|
|
23
|
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.
|
Ann Surg
|
2013
|
1.30
|
|
24
|
Wnt'er in liver: expression of Wnt and frizzled genes in mouse.
|
Hepatology
|
2007
|
1.27
|
|
25
|
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.
|
Blood
|
2008
|
1.27
|
|
26
|
Liver biopsy interpretation for causes of late liver allograft dysfunction.
|
Hepatology
|
2006
|
1.24
|
|
27
|
Azithromycin-induced intrahepatic cholestasis.
|
Dig Dis Sci
|
2002
|
1.20
|
|
28
|
Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
|
Cancer Res
|
2008
|
1.16
|
|
29
|
Histologic graft assessment after clinical islet transplantation.
|
Transplantation
|
2009
|
1.12
|
|
30
|
NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells.
|
J Immunol
|
2010
|
1.09
|
|
31
|
Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.
|
J Hepatol
|
2008
|
1.08
|
|
32
|
Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
|
Liver Transpl
|
2003
|
1.08
|
|
33
|
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.
|
Transpl Immunol
|
2005
|
1.05
|
|
34
|
Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.
|
J Immunol
|
2010
|
1.04
|
|
35
|
Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity.
|
Hepatology
|
2007
|
1.03
|
|
36
|
Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.
|
Hepatology
|
2003
|
1.03
|
|
37
|
Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
|
Liver Transpl
|
2005
|
1.02
|
|
38
|
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.
|
Transplantation
|
2012
|
1.01
|
|
39
|
Langerhans cells are not required for graft-versus-host disease.
|
Blood
|
2010
|
1.01
|
|
40
|
Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation.
|
Lab Invest
|
2005
|
1.00
|
|
41
|
Preexisting epithelial diversity in normal human livers: a tissue-tethered cytometric analysis in portal/periportal epithelial cells.
|
Hepatology
|
2013
|
0.99
|
|
42
|
Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation.
|
Transplantation
|
2007
|
0.95
|
|
43
|
Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction.
|
J Immunol
|
2012
|
0.95
|
|
44
|
Lessons of organ-induced tolerance learned from historical clinical experience.
|
Transplantation
|
2004
|
0.94
|
|
45
|
Caroli's disease and orthotopic liver transplantation.
|
Liver Transpl
|
2006
|
0.92
|
|
46
|
Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.
|
Transplantation
|
2011
|
0.91
|
|
47
|
Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation.
|
Hepatology
|
2011
|
0.91
|
|
48
|
Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation.
|
Am J Pathol
|
2012
|
0.90
|
|
49
|
An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis.
|
Hepatology
|
2005
|
0.90
|
|
50
|
Regulation and function of trefoil factor family 3 expression in the biliary tree.
|
Am J Pathol
|
2004
|
0.90
|
|
51
|
Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia/reperfusion injury.
|
Hepatology
|
2013
|
0.89
|
|
52
|
Four-color flow cytometric analysis of peripheral blood donor cell chimerism.
|
Hum Immunol
|
2003
|
0.89
|
|
53
|
Webcasting pathology department conferences in a geographically distributed medical center.
|
Hum Pathol
|
2004
|
0.89
|
|
54
|
Heterotopic breast epithelial inclusion of the heart: report of a case.
|
Am J Surg Pathol
|
2010
|
0.88
|
|
55
|
Recipient B cells are not required for graft-versus-host disease induction.
|
Biol Blood Marrow Transplant
|
2010
|
0.88
|
|
56
|
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.
|
J Hepatol
|
2002
|
0.88
|
|
57
|
Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics.
|
PLoS One
|
2012
|
0.88
|
|
58
|
Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.
|
Am J Gastroenterol
|
2006
|
0.88
|
|
59
|
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
|
Am J Surg Pathol
|
2006
|
0.88
|
|
60
|
3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury.
|
Lab Invest
|
2006
|
0.86
|
|
61
|
Small proline rich protein 2a in benign and malignant liver disease.
|
Hepatology
|
2014
|
0.85
|
|
62
|
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
|
Liver Transpl
|
2014
|
0.85
|
|
63
|
Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
|
Am J Surg Pathol
|
2008
|
0.85
|
|
64
|
Estrogen stimulates female biliary epithelial cell interleukin-6 expression in mice and humans.
|
Hepatology
|
2010
|
0.84
|
|
65
|
Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation.
|
Am J Transplant
|
2004
|
0.84
|
|
66
|
Cytosolic phospholipase A2alpha and peroxisome proliferator-activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growth.
|
Hepatology
|
2010
|
0.84
|
|
67
|
Five cases of fulminant hepatitis due to herpes simplex virus in adults.
|
Dig Dis Sci
|
2002
|
0.84
|
|
68
|
Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?
|
Liver Transpl
|
2008
|
0.83
|
|
69
|
Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts.
|
Am J Transplant
|
2003
|
0.83
|
|
70
|
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
|
Transplantation
|
2002
|
0.82
|
|
71
|
Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.
|
Blood
|
2006
|
0.82
|
|
72
|
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
|
Transplantation
|
2003
|
0.82
|
|
73
|
Acute cholestatic hepatitis associated with long-term use of rofecoxib.
|
Dig Dis Sci
|
2004
|
0.82
|
|
74
|
Memory T cells in GVHD and GVL.
|
Biol Blood Marrow Transplant
|
2008
|
0.82
|
|
75
|
Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells.
|
Transplantation
|
2002
|
0.81
|
|
76
|
Posttransplant adenoviral enteropathy in patients with small bowel transplantation.
|
Arch Pathol Lab Med
|
2008
|
0.80
|
|
77
|
HLA matching and the point system.
|
Clin Transplant
|
1993
|
0.80
|
|
78
|
SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis.
|
Clin Exp Metastasis
|
2013
|
0.79
|
|
79
|
De novo malignancies after intestinal and multivisceral transplantation.
|
Transplantation
|
2004
|
0.79
|
|
80
|
Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
|
Transplantation
|
2003
|
0.79
|
|
81
|
CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
|
J Surg Res
|
2006
|
0.79
|
|
82
|
A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies.
|
Hum Pathol
|
2004
|
0.79
|
|
83
|
Suprahepatic Budd-Chiari syndrome treated with thrombectomy and cavoplasty.
|
Dig Dis Sci
|
2003
|
0.79
|
|
84
|
Clinical xenotransplantation.
|
Xenotransplantation
|
1994
|
0.78
|
|
85
|
Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.
|
Transpl Immunol
|
2011
|
0.78
|
|
86
|
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man.
|
Transplant Sci
|
1993
|
0.78
|
|
87
|
The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts.
|
Transplantation
|
2006
|
0.78
|
|
88
|
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.
|
Liver Transpl
|
2008
|
0.78
|
|
89
|
Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features.
|
Liver Transpl
|
2014
|
0.78
|
|
90
|
Acute and chronic rejection in upper extremity transplantation: what have we learned?
|
Hand Clin
|
2011
|
0.78
|
|
91
|
Comparative analysis of the fate of donor dendritic cells and B cells and their influence on alloreactive T cell responses under tacrolimus immunosuppression.
|
Clin Immunol
|
2005
|
0.77
|
|
92
|
Protection from acute cellular injury using Sleeping Beauty mediated telomerase gene transfer.
|
Biochem Biophys Res Commun
|
2007
|
0.76
|
|
93
|
Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.
|
Curr Opin Organ Transplant
|
2016
|
0.76
|
|
94
|
Kidney/Bone Marrow Transplantation.
|
Dial Transplant
|
1996
|
0.76
|
|
95
|
The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft.
|
J Surg Res
|
2011
|
0.76
|
|
96
|
Cholestatic jaundice and bone lesions in an elderly woman.
|
Nat Clin Pract Gastroenterol Hepatol
|
2004
|
0.76
|
|
97
|
SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
|
BMC Mol Biol
|
2012
|
0.76
|
|
98
|
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.
|
Xenotransplantation
|
1997
|
0.75
|
|
99
|
Early HCV-associated stellate cell activation in aggressive recurrent HCV: what can liver allografts teach about HCV pathogenesis?
|
Liver Transpl
|
2005
|
0.75
|
|
100
|
Prevention of Transplant Rejection: Can Tolerance be Achieved with Immunosuppressive Treatment?
|
Clin Immunother
|
1996
|
0.75
|
|
101
|
The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction.
|
Transplant Sci
|
1993
|
0.75
|
|
102
|
Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR score's Ability to Determine Long-Term Outcome.
|
Transplantation
|
2017
|
0.75
|
|
103
|
Cholangiopathy: genetics, mechanism, and pathology.
|
Int J Hepatol
|
2011
|
0.75
|
|
104
|
Non-HLA Antibodies Impact on C4d staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
|
Transplantation
|
2017
|
0.75
|